TOMI’s SteraMist Enclosure Sales Surge to $2.3M YTD, 44% Above Prior Four-Year Total
Event summary
- TOMI’s SteraMist iHP enclosure sales hit $2.3M YTD, a 44% increase over the prior four-year total of $1.6M.
- Recent purchase orders totaling $2.3M are expected to be recognized as revenue in Q3-Q4 2026.
- The company’s SteraMist Integrated System (SIS) platform has accelerated order closings and retrofits.
- Two recent orders involve retrofitting SteraMist iHP into existing customer enclosures, displacing chlorine dioxide and other decontamination methods.
- TOMI is developing a standardized SteraBox for recycling and circular-economy applications.
The big picture
TOMI’s shift to a standardized SteraMist Integrated System (SIS) platform has significantly reduced customization requirements, accelerating order closings and revenue recognition. This strategic move aligns with broader industry trends towards modular and flexible decontamination solutions, particularly in life sciences and sustainability-driven operations. The company’s ability to retrofit existing equipment with SteraMist iHP technology positions it favorably in a market increasingly valuing cost-effective and high-efficiency decontamination solutions.
What we're watching
- Market Expansion
- Whether TOMI can sustain the rapid growth in SteraMist iHP enclosure sales beyond the life sciences sector.
- Execution Risk
- The pace at which TOMI can deliver on the $3.2M active pipeline of automated custom-design work.
- Product Differentiation
- How the standardized SteraBox will perform in recycling and circular-economy markets compared to traditional decontamination methods.
Related topics
